—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Insulet Corporation (PODD) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for PODD, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 0.46 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How PODD has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.46 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Insulet Corporation moved 0.46% on average · correlation 0.10 · higher than 47% of US names
  • Beta, last 3 months 0.33 about the same as over the year
  • On the 10 worst bond days −1.40% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.52% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against PODD on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Insulet Corporation

PODD in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Insulet makes wearable insulin pumps for people with diabetes who need constant insulin dosing. Its main product, Omnipod 5, is a tubeless pod that links wirelessly to a third-party glucose sensor and adjusts insulin delivery automatically. An older version, Omnipod DASH, uses a handheld controller instead of full automation. It also makes a version of its pod for Amgen's chemotherapy support device. Insulet sells through pharmacies and distributors and is based in Acton, Massachusetts.
Where it sits in the stack
Insulet has no seat in our chip-and-infrastructure index; it sits in the diary's HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, which groups regulated device makers with long product cycles.
Who it is priced against
Closelooknet's peer group places it with other device and diagnostics names built on regulatory moats — Intuitive Surgical, Stryker, DexCom, IDEXX Laboratories, Globus Medical, Sonova and Sartorius; the market also names Medtronic, whose insulin pumps compete directly with Omnipod.
Why Closelooknet tracks it
It holds a seat in HALO Growth 100 but carries no Closelooknet score yet, and the diary has not quoted it in any recent edition.
What the diary watches
Whether Omnipod 5's automatic dosing keeps taking pump share as glucose-sensor makers widen who they connect with, since that link decides how much of the diabetes market runs through Insulet's pods.

Insulet Corporation (PODD) trades on US exchanges. Constituent of HALO Growth 100.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: initiation by Barclays, 2026-10-06

The Street on this name

Analyst actions and the latest print for PODD from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation Barclays — at Positive Initiated to Positive from Underweight 2026-10-06

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Insulet Corporation (PODD)?

Insulet Corporation trades as PODD on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is PODD in a Closelooknet index?

Yes — Insulet Corporation is a constituent of HALO Growth 100, as of 2026-10-07.

Where does PODD trade against its moving averages?

Downtrend stack: Trades -6.5% vs the 50-day and -29.8% vs the 200-day average, 62% below the 52-week high and +6.6% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Insulet Corporation compare with its peers?

Against its peer group (HALO Growth 100 · Surgical, Med Devices & Animal Health), Insulet Corporation (PODD) sits 62.0% below its 52-week high, 6.5% below its 50-day average; DexCom Inc (DXCM) is 6.1% below, Intuitive Surgical Inc (ISRG) is 32.7% below, Sartorius AG VZO O.N. (SRT.DE) is 5.8% below. Put any of them next to PODD in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Insulet Corporation trade when bond yields rise?

Over the past year Insulet Corporation had a beta of 0.46 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 47% of US names. On the 10 sessions in which long bonds fell most it moved −1.40% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Insulet Corporation do?

Insulet makes wearable insulin pumps for people with diabetes who need constant insulin dosing. Its main product, Omnipod 5, is a tubeless pod that links wirelessly to a third-party glucose sensor and adjusts insulin delivery automatically. An older version, Omnipod DASH, uses a handheld controller instead of full automation. Closelooknet's peer group places it with other device and diagnostics names built on regulatory moats — Intuitive Surgical, Stryker, DexCom, IDEXX Laboratories, Globus Medical, Sonova and Sartorius; the market also names Medtronic, whose insulin pumps compete directly with Omnipod.

Where does Insulet Corporation sit in the AI build-out?

Insulet has no seat in our chip-and-infrastructure index; it sits in the diary's HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, which groups regulated device makers with long product cycles. It holds a seat in HALO Growth 100 but carries no Closelooknet score yet, and the diary has not quoted it in any recent edition.

What has Wall Street done on Insulet Corporation recently?

The most recent analyst action on Insulet Corporation on the Closelooknet wire is a initiation by Barclays on 2026-10-06 (at Positive). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for PODD, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.